Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-10

FDA Approved: LURASIDONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved Aurobindo Pharma Limited's original ANDA for lurasidone hydrochloride, a generic antipsychotic indicated for schizophrenia and bipolar depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lurasidone hydrochloride (Lurasidone hydrochloride)

Snippet

ORIG AP for LURASIDONE HYDROCHLORIDE (LURASIDONE HYDROCHLORIDE)